Carlsmed Raises FY2026 Sales Guidance from $72.000M-$77.000M to $74.000M-$78.000M vs $74.830M Est

Benzinga Newsdesk www.benzinga.com Positive 93.5%

Neg 0% Neu 0% Pos 93.5%

Carlsmed (NASDAQ:CARL) raises FY2026 sales outlook from $72.000 million-$77.000 million to $74.000 million-$78.000 million vs $74.830 million estimate.